News - 13 Mar `22Vitiligo Clinical Trials update

New

Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective.

Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." Our own Vitiligo Drug Pipeline Analysis and Market Insights analyzes and monitors the entire development landscape along with the trends shaping and driving the vitiligo market. For example, Ruxolitinib cream (currently marketed under the brand name Opzelura) for vitiligo treatment is on FDA's fast track.

On the Trials Hub page you'll find a comprehensive listing with current clinical trials, including the most recent announcements from Vitiligo Center at UMass in Boston, MA or Tel-Aviv Sourasky Medical Center in Israel.